Showing posts with label Regenerative Medicine. Show all posts
Showing posts with label Regenerative Medicine. Show all posts

Monday, 16 July 2018

Size and Share of Regenerative Medicine Market in Global Industry : Insights, Development, Research and Forecast 2018-2025

ResearchMoz presents professional and in-depth study of "Global Regenerative Medicine Market Size,Status and Forecast 2025".

This report studies the global Regenerative Medicine market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Regenerative Medicine market by companies, region, type and end-use industry.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1835871

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the bodys innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.

USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.

According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.

Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-regenerative-medicine-market-sizestatus-and-forecast-2025-report.html/toc

The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.

In 2017, the global Regenerative Medicine market size was 5350 million US$ and it is expected to reach 28800 million US$ by the end of 2025, with a CAGR of 23.4% during 2018-2025.

This report focuses on the global top players, covered
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Cell Therapy
Tissue Engineering
Biomaterial
Other

Market segment by Application, split into
Dermatology
Cardiovascular
CNS
Orthopedic
Others

The study objectives of this report are:
To study and forecast the market size of Regenerative Medicine in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Regenerative Medicine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Regenerative Medicine Manufacturers
Regenerative Medicine Distributors/Traders/Wholesalers
Regenerative Medicine Subcomponent Manufacturers
Industry Association
Downstream Vendors

Browse Report @ https://www.researchmoz.us/global-regenerative-medicine-market-sizestatus-and-forecast-2025-report.html

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Regenerative Medicine market, by end-use.
Detailed analysis and profiles of additional market players.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Wednesday, 18 April 2018

Analysis of Regenerative Medicine Market in Global Industry : Market Development and Overview 2018

ResearchMoz presents professional and in-depth study of "Global Regenerative Medicine Market Analysis & Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries".

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth $18.9 billion in 2016 and will grow to over $53.7 billion by 2021, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry will grow significantly at a CAGR of over x% and reach $x billion by 2021.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1714466

Tissue engineering is forecast to grow at a CAGR of x% to 2021 and potentially reach $x billion. This report describes the evolution of such a huge market in 15 chapters supported by over 350 tables and figures in 680 pages.

    An overview of regenerative medicine that includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies.
    Global regenerative medicine market, global breakdown, application breakdown and leading market players
    Detailed account of the stem cell industry market by geography, indication and company profiles
    Profiles, marketed/pipeline products, financial analysis and business strategy of the major companies in this space
    Focus on current trends, business environment, pipeline products, clinical trials, and future market forecast for regenerative medicine
    Insight into the challenges faced by stakeholders, particularly about the success vs. failure ratios in developing regenerative medicine drugs and therapies.
    Insight into the biobanking industry globally and its impact on the overall market
    Description and data for the prevalence of disease types that are addressed by regenerative medicine, stem cells, tissue engineering and CAR-T therapies
    Financial market forecast through 2021 with CAGR values of all market segments outlined in the objective
    SWOT analysis of the global market
    Geographical analysis and challenges within key topographies including the USA, Japan, South Korea, China and Europe

View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-regenerative-medicine-market-analysis-forecast-to-2021-stem-cells-tissue-engineering-biobanking-cart-industries-report.html/toc

Table of Content

1.0 Report Synopsis
1.1 Objectives of Report
1.2 Executive Summary
1.2 Key Questions Answered in this Report
1.3 Data Sources and Methodology

2.0 Introduction
2.1 Gurdon and Yamanaka Share the Nobel Prize
2.2 Stem Cell Clinical Trials: Initiated in 2010
2.3 Types of Stem Cells
2.4 Adult (Tissue) Stem Cells
2.5 Pluripotent Stem Cells
2.6 Somatic Cell Nuclear Transfer (SCNT)
2.7 Induced pluripotent Stem Cells (iPSC)
2.8 Mesenchymal Cells
2.8.1 MSCs in the Bone Marrow Stroma
2.8.2 Isolation, Marker Specificity and Functional Properties of MSCs
2.8.3 Oxygen Concentration and MSC Culture
2.8.4 Assays to Define MSCs
2.8.5 Differentiation Potential of MSCs
2.8.6 Therapeutic Potential of MSCs
2.8.7 Mesenchymal Stem Cells & Chronic Disease
2.8.8 MSCs and Amylotrophic Lateral Sclerosis
2.8.9 MSCs and Parkinson’s Disease
2.8.10 MSCs and Alzheimer Disease

Browse Report @ https://www.researchmoz.us/global-regenerative-medicine-market-analysis-forecast-to-2021-stem-cells-tissue-engineering-biobanking-cart-industries-report.html

2.8.11 MSCs and Rheumatoid Arthritis
2.8.12 MSCs and Type 1 Diabetes
2.8.13 MSCs and Cardiovascular Disease
2.9 Hematopoietic Stem and Progenitor Cells
2.9.1 In Vivo Assays for Hematopoietic Stem Cells

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Tuesday, 4 April 2017

At A CAGR Of 35.3% , Regenerative Medicine Market in Japan will rise in the period of 2017-2020

ResearchMoz presents professional and in-depth study of "Regenerative Medicine Market in Japan 2016-2020".

Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat damaged or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, gene therapy, and cell therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues, whereas cell therapy helps in treating the functioning of existing cells.

Technavios analysts forecast the regenerative medicine market in Japan to grow at a CAGR of 35.3% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the regenerative medicine market in Japan for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of regenerative medicine products to end-users like hospitals, ambulatory surgical centers (ASCs), and clinical research laboratories.

The market is divided into the following segments based on product:
Tissue Scaffold
Cell Therapy

Technavio's report, Regenerative Medicine Market in Japan 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=834764

Key vendors
CellSeed
JCR Pharmaceuticals
Japan Tissue Engineering
Terumo
Astellas
Caladrius Biosciences
Healios
Fujifilm
Rohto Pharmaceuticals

Other prominent vendors
FUJISOFT Tissue Engineering
MediBIC
MEDI NET
Nikon
TAKARA
CMIC
EPS
Cyfuse Biomedical
Irvine Scientific
Kaken
Regience
Sumitomo Dainippon
Takeda
Alfresa
MEDIPAL Holdings
TOHO

Market driver
Growing partnerships of MNCs with local vendors in Japan
For a full, detailed list, view our report

Market challenge
High cost and failure rate in clinical trials coupled with inadequate clinical evidence
For a full, detailed list, view our report

Market trend
Strong pipeline portfolio of regenerative medicines
For a full, detailed list, view our report

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=834764

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://mymarketresearchlifereports.blogspot.in/